{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T14:08:44Z","timestamp":1769263724420,"version":"3.49.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1136\/annrheumdis-2020-217877","type":"journal-article","created":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T21:17:18Z","timestamp":1591391838000},"page":"851-858","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":202,"title":["EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0577-6620","authenticated-orcid":false,"given":"Robert BM","family":"Landew\u00e9","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8411-7972","authenticated-orcid":false,"given":"Pedro M","family":"Machado","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8940-0582","authenticated-orcid":false,"given":"F\u00e9line","family":"Kroon","sequence":"additional","affiliation":[]},{"given":"Hans WJ","family":"Bijlsma","sequence":"additional","affiliation":[]},{"given":"Gerd R","family":"Burmester","sequence":"additional","affiliation":[]},{"given":"Loreto","family":"Carmona","sequence":"additional","affiliation":[]},{"given":"Bernard","family":"Combe","sequence":"additional","affiliation":[]},{"given":"Massimo","family":"Galli","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-310X","authenticated-orcid":false,"given":"Laure","family":"Gossec","sequence":"additional","affiliation":[]},{"given":"Annamaria","family":"Iagnocco","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6103-7056","authenticated-orcid":false,"given":"John D","family":"Isaacs","sequence":"additional","affiliation":[]},{"given":"Xavier","family":"Mariette","sequence":"additional","affiliation":[]},{"given":"Iain","family":"McInnes","sequence":"additional","affiliation":[]},{"given":"Ulf","family":"Mueller-Ladner","sequence":"additional","affiliation":[]},{"given":"Peter","family":"Openshaw","sequence":"additional","affiliation":[]},{"given":"Josef S","family":"Smolen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3073-7284","authenticated-orcid":false,"given":"Tanja A","family":"Stamm","sequence":"additional","affiliation":[]},{"given":"Dieter","family":"Wiek","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1681-491X","authenticated-orcid":false,"given":"Hendrik","family":"Schulze-Koops","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2020-217877_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1136\/annrheumdis-2014-206350","article-title":"2014 update of the EULAR standardised operating procedures for EULAR-endorsed recommendations","volume":"74","author":"van der Heijde","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-217877_bib2","unstructured":"Commission for pharmacotherapy and the Board of the German Society for rheumatology e.V. Aktuelle Handlungsempfehlungen Der Deutschen Gesellschaft f\u00fcr Rheumatologie e.V. f\u00fcr die Betreuung von Patienten MIT rheumatischen Erkrankungen w\u00e4hrend Der SARS-CoV-2\/Covid 19-Pandemie. Available: https:\/\/dgrh.de\/Start\/Publikationen\/Empfehlungen\/Therapie-bei-besonderen-Situationen\/Empfehlungen-w%C3%A4hrend-der-SARS-CoV-2-Covid-19-Pandemie.html [Accessed 24 Mar 2020]."},{"key":"10.1136\/annrheumdis-2020-217877_bib3","unstructured":"Fili\u00e8re de sant\u00e9 maladies rares. Recommandations COVID-19 : Patients atteints de maladies auto-immunes ou auto-inflammatoires. Available: https:\/\/www.fai2r.org\/actualites\/covid-19 [Accessed 09 Apr 2020]."},{"key":"10.1136\/annrheumdis-2020-217877_bib4","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de Rhumatologie. R\u00e9ponse donner aux patients qui posent des questions SUR Le Risque que constitue leur traitement face Au COVID-19. Available: https:\/\/sfr.larhumatologie.fr\/actualites\/reponse-donner-aux-patients-qui-posent-questions-risque-que-constitue-leur-traitement [Accessed 17 Mar 2020]."},{"key":"10.1136\/annrheumdis-2020-217877_bib5","unstructured":"La Sociedad Espa\u00f1ola de Reumatolog\u00eda. El coronavirus COVID-19 Y Los pacientes Con Enfermedades reum\u00e1ticas. Available: https:\/\/www.ser.es\/el-coronavirus-covid-19-y-los-pacientes-con-enfermedades-reumaticas\/ [Accessed 31 Mar 2020]."},{"key":"10.1136\/annrheumdis-2020-217877_bib6","unstructured":"National Health Service. Clinical guide for the management of rheumatology patients during the coronavirus pandemic. Available: https:\/\/www.england.nhs.uk\/coronavirus\/wp-content\/uploads\/sites\/52\/2020\/03\/clinical-guide-rheumatology-patients-v2-08-april-2020.pdf [Accessed 8 Apr 2020]."},{"key":"10.1136\/annrheumdis-2020-217877_bib7","unstructured":"National Institute for Health and Care Excellence. COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders. NICE guideline [NG167], 2020. Available: https:\/\/www.nice.org.uk\/guidance\/ng167 [Accessed 03 Apr 2020]."},{"key":"10.1136\/annrheumdis-2020-217877_bib8","unstructured":"World Health Organization. Coronavirus disease (COVID-19) pandemic, 2020. Available: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019"},{"key":"10.1136\/annrheumdis-2020-217877_bib9","unstructured":"ACR COVID-19 Clinical Guidance Task Force. COVID-19 clinical guidance for adult patients with rheumatic diseases. draft summary. Available: https:\/\/www.rheumatology.org\/Portals\/0\/Files\/ACR-COVID-19-Clinical-Guidance-Summary-Patients-with-Rheumatic-Diseases.pdf [Accessed 14 Apr 2020]."},{"key":"10.1136\/annrheumdis-2020-217877_bib10","unstructured":"Robert Koch Institut. Informationen und Hilfestellungen f\u00fcr Personen MIT einem h\u00f6heren Risiko f\u00fcr einen schweren COVID-19-Krankheitsverlauf. Available: https:\/\/www.rki.de\/DE\/Content\/InfAZ\/N\/Neuartiges_Coronavirus\/Risikogruppen.html [Accessed 23 Mar 2020]."},{"key":"10.1136\/annrheumdis-2020-217877_bib11","unstructured":"Swiss Federal Office of Public Health. Ordinance on measures to combat the coronavirus (COVID-19). Available: https:\/\/www.admin.ch\/opc\/en\/classified-compilation\/20200744\/index.html [Accessed 13 Mar 2020]."},{"key":"10.1136\/annrheumdis-2020-217877_bib12","unstructured":"European Centre for Disease Prevention and Control. Factsheet for health professionals on coronaviruses. Available: https:\/\/www.ecdc.europa.eu\/en\/factsheet-health-professionals-coronaviruses [Accessed 30 Jan 2020]."},{"key":"10.1136\/annrheumdis-2020-217877_bib13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMsr1408795","article-title":"Middle East respiratory syndrome","volume":"376","author":"Arabi","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1136\/annrheumdis-2020-217877_bib14","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s10067-006-0441-9","article-title":"Infection-Related morbidity and mortality in patients with connective tissue diseases: a systematic review","volume":"26","author":"Falagas","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2020-217877_bib15","doi-asserted-by":"crossref","first-page":"e000935","DOI":"10.1136\/rmdopen-2019-000935","article-title":"Serious infection risk in rheumatoid arthritis compared with non-inflammatory rheumatic and musculoskeletal diseases: a US national cohort study","volume":"5","author":"Mehta","year":"2019","journal-title":"RMD Open"},{"key":"10.1136\/annrheumdis-2020-217877_bib16","unstructured":"National Health Commission & State Administration of Traditional Chinese Medicine. Diagnosis and treatment protocol for novel coronavirus pneumonia (trial version 7). Available: https:\/\/covid-19.chinadaily.com.cn\/ [Accessed 3 Mar 2020]."},{"key":"10.1136\/annrheumdis-2020-217877_bib17","unstructured":"Cohen E, Cohen M. After Trump's statements about hydroxychloroquine, lupus and arthritis patients face drug shortage. Available: https:\/\/edition.cnn.com\/2020\/04\/07\/health\/hydroxychloroquine-shortage-lupus-arthritis\/index.html [Accessed 7 Apr 2020]."},{"key":"10.1136\/annrheumdis-2020-217877_bib18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2020-217877_bib19","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1136\/annrheumdis-2013-203249","article-title":"EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases","volume":"72","author":"Duru","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-217877_bib20","first-page":"24","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese center for disease control and prevention","volume":"2020","author":"Wu","year":"2019","journal-title":"JAMA"},{"key":"10.1136\/annrheumdis-2020-217877_bib21","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1126\/science.abb8034","article-title":"Misguided drug advice for COVID-19","volume":"367","author":"FitzGerald","year":"2020","journal-title":"Science"},{"key":"10.1136\/annrheumdis-2020-217877_bib22","doi-asserted-by":"crossref","first-page":"e208857","DOI":"10.1001\/jamanetworkopen.2020.8857","article-title":"Effect of high vs low doses of chloroquine diphosphate as adjunctive therapy for patients hospitalized with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection","volume":"3","author":"Borba","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1136\/annrheumdis-2020-217877_bib23","first-page":"39","article-title":"Update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases","volume":"2020","author":"Furer","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-217877_bib24","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1136\/annrheumdis-2016-209133","article-title":"EULAR\/ERA-EDTA recommendations for the management of ANCA-associated vasculitis","volume":"75","author":"Yates","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2020-217877_bib25","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1136\/annrheumdis-2020-217877_bib26","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1002\/art.38690","article-title":"Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome","volume":"66","author":"Fardet","year":"2014","journal-title":"Arthritis Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724013189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724013189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2020-217877","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T23:02:49Z","timestamp":1737241369000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724013189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0003496724013189"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2020-217877","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2020-217877","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 \u00a9 Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}